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Abstract
International Classification of Diseases the 10th Revision (ICD-10) was implemented
October 1, 2015, and there was little knowledge how the transition to ICD-10 would
impact the revenue cycle for intraoperative neurophysiological monitoring medical
practices in Oklahoma. This correlational quantitative study examined the changes in
dependent variables of reimbursements due to the change from ICD-9 to ICD-10 for
independent variables of intraoperative neurophysiological monitoring procedure codes.
The reimbursements from 2014 were compared to reimbursements from 2016. Prices
were adjusted for inflation to 2016 dollar values. Annual reimbursements decreased for
all intraoperative neurophysiological monitoring procedures examined except the remote
monitoring code. The intraoperative neurophysiological monitoring procedure with the
greatest mean annual decreases in reimbursement was the lower somatosensory evoked
potentials. The intraoperative neurophysiological monitoring procedures with the least
annual reimbursement decreases were transcranial electrical motor potential monitoring
and electromyography. The findings of the budget-impact analysis and cost-effectiveness
analysis indicated that reimbursement for procedures has steadily decreased from 2014 to
2016, causing a negative effect on practices’ revenue cycle management. The findings of
this study could benefit intraoperative neurophysiological monitoring companies in
Oklahoma by supporting adjustments essential for healthcare leaders to maintain a
financially sustainable intraoperative neurophysiological monitoring medical practice.
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Section 1: Foundation of the Study and Literature Review
Introduction
The changes in medical coding from International Classification of Diseases
(ICD) 9th to the 10th revision was a massive undertaking by physicians, hospitals, and
clinics. The positive and negative effects of this change have been uncovered for
specialties across the United States. This study will evaluate the changes in
reimbursements due to the change from ICD-9 to ICD-10 for intraoperative
neurophysiological monitoring in Oklahoma. There are several small intraoperative
neurophysiological monitoring companies in Oklahoma and these changes may affect
their livelihood. Without a study on the changes in reimbursement, these companies
could cease to be financially solvent. The potential positive social change implications of
the study will assist healthcare leadership to understand these changes to be able to make
the necessary changes in business. It could also assist their revenue cycle management to
ensure the stability and future of Oklahoma intraoperative neurophysiological monitoring
companies. This section will cover the background, purpose, theoretical framework of
the problem, and research questions.
Background
Knowledge regarding the business effects of reimbursement changes is
fundamental for any healthcare organization. Without effective leadership, healthcare
organizations can experience difficulty establishing processes to stay compliant and
profitable (Colton & Wofford, 2013).
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Rethinking revenue cycle management by understanding financial implications
will allow intraoperative neurophysiological monitoring leadership to ensure competitive
advantage and to grow (Hackbarth & Gamble, 2017). Revenue cycle management
includes an office’s medical claims processing, payments, and revenue generation. The
office processes patient eligibility, collection of copays, claims coding, claims tracking,
payment collection, and follow-up of denied claims (Bentley & Robinson, 2016). Loss of
revenue and reimbursements occurs through inappropriate use of ICD-10.
Data analytics, contract management, coding, and denial of claims management
represent key pieces of the revenue cycle management for a practice manager’s review
(Cerner, 2017). The concepts of business operations and implementation best practices
can be lost, which affect the financial viability of the practice. This is because providers
are too busy with patient care as they focus on clinical aspects instead of management
(Healthcare Financial Management Association [HFMA], 2015).
Padarthy (2012) described the conversion of code sets as touching every aspect of
the practice from patient care to data analysis. The conversion from ICD-9 to ICD-10
affects every part of healthcare business requiring an analysis to determine the overall
effects. A financial impact analysis will assess the changes in reimbursement. The
changes in reimbursements caused by the change from ICD-9 to ICD-10 must be studied
to ensure the financial stability of the practice and specialty.
The estimated time and cost of the revenue cycle for an inpatient surgical
procedure is 100 minutes with reimbursement of $215.10 per procedure, which accounts
for 3.1% of total revenues (Tseng, Kaplan, Richman, Shah, & Schulman, 2018). With
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administrative costs estimated at 25-31% of total health care expenditures in the United
States (Tseng et al., 2018), an understanding of the changes in reimbursements will
enable intraoperative neurophysiological monitoring company leaders to optimize
revenues. The financial benefits of an effective revenue cycle management process
comprise a linear relationship between the measurement of the effectiveness with positive
outcomes (Singh, Mindel, & Mathiassen, 2017). Practice leaders need to understand the
revenue and reimbursement requirements to effectively make decisions for the company
(Fang & Li, 2015). The ICD-10 implementation affected everyone and all resources
within a health system (Leenheer, 2012). Since the implementation of ICD-10 on
October 1, 2015, I did not find literature regarding the effect to the revenue cycle for
intraoperative neurophysiological monitoring.
Problem Statement
When ICD10 was implemented, there was little knowledge of how that transition
would impact the revenue cycle for intraoperative neurophysiological monitoring medical
practices in Oklahoma. The increased costs of implementing the ICD-10-CM were not
studied previously to determine the effect on reimbursement rates for intraoperative
neurophysiological monitoring medical practices in Oklahoma for healthcare leadership.
Knowledge of the reimbursement changes and the effects on the business are
fundamental for any healthcare organization to survive and to thrive in the market.
Without effective healthcare leadership, the organizations will have a difficult
time establishing the required processes to stay compliant and profitable (Colton &
Wofford, 2013). The intraoperative neurophysiological monitoring industry constantly
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changes with new companies as well as acquisitions in the area and surrounding states
such as the NuVasive, Inc. acquisition of NeuroNetwork, LLC for 98 million dollars (PR,
2017). The intraoperative neurophysiological monitoring market is expected to reach
$3.6 billion by 2025, which caused intraoperative neurophysiological monitoring
acceptance as a standard of care due to its benefits (PR, 2017). More research about the
importance of accurate use was needed for healthcare administrators’ use in
intraoperative neurophysiological monitoring. The literature contains information on
revenue cycle management, but it does not include specific information on intraoperative
neurophysiological monitoring other than a few blogs.
Purpose
The purpose of this correlational, quantitative study was to provide understanding
specific for health care leaders regarding the changes in reimbursement following ICD-10
implementation in intraoperative neurophysiological monitoring companies in Oklahoma.
In this project I addressed the lack of research specific to the administrative side of
intraoperative neurophysiological monitoring. The results of this study may provide
much-needed insights into the actual changes that affects this industry allowing
healthcare revenue cycle managers and management to adjust business practices to stay
profitable. There is a gap in studies on the changes in reimbursement following ICD-10
implementation in most specialties, especially intraoperative neurophysiological
monitoring companies. The variables that will be studied will be the Current Procedural
Terminology (CPT) codes for intraoperative neurophysiological monitoring and the
reimbursements for each code specific to a variety of insurance companies, such as
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Medicare, Medicaid, and average of commercial insurance carriers following the ICD-10
implementation years. The relationship between the CPT code and the reimbursement
amount centers on payment differences to physicians and other providers who earn their
income based on the services they provide (CPT) and were paid by insurance companies
(reimbursements) based on the CPT codes performed and submitted. The ICD-10 coding
is the major change in coding for the diagnosis or the reason for the CPT/procedure. The
specification requirements for ICD-10 determine whether documentation by providers
meets guidelines of payment codes. The physicians’ in specialties such as orthopedics
were at risk of losing revenue due to poor documentation (Lussier et al., 2016). This
research may provide information for leadership to use for a better understanding of the
effect of changes in reimbursements following ICD-10 implementation for intraoperative
neurophysiological monitoring.
Research Questions and Hypothesis
The overarching research question is: What is the statistical significance, if any,
between the changes in reimbursements from following the ICD-10 implementation in
intraoperative neurophysiological monitoring companies in Oklahoma? The datasets will
provide the reimbursements per CPT code for 2014 and 2016 to include before ICD-10
implementation and following. The CPT codes for the study are listed below in addition
to the research questions. I included Medicare, Medicaid, and other commercial
insurance carriers in this study.
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Table 1
CPT Codes for Intraoperative Neurophysiological Monitoring
CPT Code
G0453
95925
95926
95938
95927
95928
95939
95937
95861
95870
51785
95812
95813

Description
Remote Intraoperative Monitoring
Upper SSEP Bilateral
Lower SSEP Bilateral
Upper & Lower SSEP Bilateral
Trunk/Head SSEP Bilateral
TcMEP Upper Limbs
TcMEP Upper & Lower Limbs
NeuroMusclular Junction (TOF)
EMG Two Extremity
Trunk/Extremity EMG
Anal Sphincter
EEG 41-60 minutes
EEG greater than 1 hour

Research Question1: To what extent was the difference, if any, between the
independent variables of intraoperative neurophysiological monitoring CPT codes and
dependent continuous variables within the Medicare Fee Schedule for 2014 and 2016 for
intraoperative neurophysiological monitoring companies in Oklahoma?
H01: There was not a statistically significant difference on independent variables
of intraoperative neurophysiological monitoring CPT codes and dependent continuous
variables of the Medicare Fee Schedule for 2014 and 2016.
Ha1: There was a statistically significant difference on independent variables of
intraoperative neurophysiological monitoring CPT codes and dependent continuous
variables of the Medicare Fee Schedule for 2014 and 2016.
Research Question 2: What was the difference between the independent variables
of intraoperative neurophysiological monitoring CPT codes and the dependent
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continuous variables of the rate paid by commercial carriers for 2014 and 2016 for
intraoperative neurophysiological monitoring companies in Oklahoma?
H02: There was not a statistically significant difference between the independent
variables of intraoperative neurophysiological monitoring CPT codes and dependent
continuous variables of the rate paid by commercial carriers for 2014 and 2016.
Ha2: There was a statistically significant difference between the independent
variables of intraoperative neurophysiological monitoring CPT codes and dependent
continuous variables of the rate paid by commercial carriers for 2014 and 2016.
Research Question 3: How did the conversion from ICD-9 to ICD-10 (i.e., 2014
versus 2016) affect the revenue cycle management for intraoperative neurophysiological
monitoring companies in Oklahoma?
H03: The conversion from ICD-9 to ICD-10 (i.e., 2014 versus 2016) positively
affected the revenue cycle management for intraoperative neurophysiological monitoring
companies in Oklahoma.
Ha3: The conversion from ICD-9 to ICD-10 (i.e., 2014 versus 2016) negatively
affected the revenue cycle management for intraoperative neurophysiological monitoring
companies in Oklahoma.
Theoretical Foundation
The theoretical base or conceptual framework that grounded the study is budget
impact analysis and cost-effectiveness analysis. The changes in reimbursements for
intraoperative neurophysiological monitoring requires a broad view of budget impact
analysis and cost-effectiveness analysis for the effects on short-term and long-term
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practice management and revenue cycle management considerations (Bilinski et al.,
2017). Cost-effectiveness and budget impact analysis will enable practice managers to
design the revenue cycle department for intraoperative neuromonitoring companies to be
successful and closes the gap between cost-effectiveness and affordability (Bilinski et al.,
2017). Cutler and Ericson (2010) used cost-effectiveness analysis with the social cost
and posted prices in the pharmaceutical industry.
Nature of the Study
The nature of the study will be a quantitative research approach, which is
appropriate for the topic identified in the problem statement of reimbursement rates in
intraoperative neurophysiological monitoring. The independent variables of
intraoperative neurophysiological monitoring CPT codes will be compared to the
dependent variables of insurance reimbursements and the Medicare Fee Schedule for the
year 2014 and 2016 through statistical testing of sample t test.
The variances in reimbursement for the CPT codes used in intraoperative
neurophysiological monitoring from 2014 to 2016 will be analyzed, which is the period
of the conversion from ICD-9 to ICD-10. To account for the possible yearly inflation
allowed in the codes, a review of the allowable codes from each year will be used for
comparison regarding what was paid and compared to the percentage of Medicare rates.
Literature Search Strategy
The literature review integrated comprehensive research on the topics of
intraoperative neurophysiological monitoring and reimbursements. Various search
methods were used on medical association websites, medical affiliated organizations
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websites, government websites, and primary source reports. Peer-reviewed literature,
studies, and dissertations were retrieved from Walden University’s online library system,
Google Scholar, PubMed, Medline, Proquest, and EBSCOHost using the keywords:
intraoperative neurophysiological monitoring with revenue, reimbursements, practice
management, revenue cycle management, cash flow, financials, revenue stream, ICD-10,
medical billing, and coding. The search resulted in a limited number of scholarly
references on the specific area of study of intraoperative neurophysiological monitoring
and administrative terms. Research on intraoperative neurophysiological monitoring was
found, but nothing on the administration (nonclinical) aspect. Research is available on
ICD-10 implantation terms such as revenue cycle management, revenue stream and
finance but not within the past 5 years. ICD-10 was announced by the United States
Department of Health and Human Services on July 31, 2014, that ICD-10-CM and ICD10-PCS will be implemented into the HIPAA mandated code set on Oct 1, 2015
(Nicoletti, 2014). The literature examined provided a knowledge base for the study.
Change in Reimbursement Studies
Eltorai et al. (2018) explored trends in Medicare reimbursements for orthopedic
procedures from 2000 to 2016 and determined that there was a decrease in the
reimbursements for the procedures but not the implants. The researchers used the most
common orthopedic procedures and Medicare fee schedule to compare the data from
2000 and 2016 while adjusting the 2000 fees to the 2016 dollars (Eltorai et al., 2018).
Eltorai et al. indicated the limitations to only using Medicare data, because there was no
access to private commercial carriers. While Eltorai et al. conducted their study with a

10
theoretical background and timeframe similar to the current study, the specialty and
geographical region was different.
Jones, Scott, Anoff, Pierce, and Glasheen (2015) studied the changes in the payer
mix and physician reimbursement after the Affordable Care Act and Medicaid
Expansion. They determined there was an increase in visits for Medicaid with a decrease
in uninsured and commercial visits with a small increase in physician reimbursements.
Jones et al. noted a major limitation on as single center analysis of data and suggested
further research for hospital and physician practices in both Medicaid expansion and no
expansion states on the impact of the ACA and Medicaid expansion on reimbursement
(Jones et al., 2015). The changes in reimbursements after major modifications to the
system needed to be study to determine the effects.
Riley, Withy, Rogers, DuBose-Morris, and Kurozawa (2017) studied the private
insurance and Medicare reimbursement rates of CPT code 99213 (Established patient
level 3 evaluation and management) for the year 2012 using secondary data to compare to
the cost of living in the area for 490 localities across the United States. Riley et al. found
that Hawai’i has the lowest physicians’ annual wages in terms of the adjusted cost of
living and reimbursements for 99213. Riley et al. indicated limitations of inability to
compare data from multiple data sources and future research could include researching
the satisfaction levels of physicians in areas with improved reimbursements.
Witte, MacPhee, Ginsburg, and Deshmukh (2017) studied Medicaid
reimbursements from 2004 to 2014 to determine if the Patient Protection and Affordable
Care Act from 2010 influenced coverage of the female condom. Witte et al. concluded
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that 26 states reimburse and 14 do not, which constituted a 33% increase from 2007. The
study limitations were indicated as data challenges for actual usage data for the states that
provide reimbursement (Witte et al., 2017).
Hempstead, Sung, Gray, and Richardson (2015) studied the trends in provider
reimbursements and patient obligations for Athena health providers between 2013 and
2014. More than 17 million visits to nearly 15,000 providers resulted in primary care
payments increased by 3.8% and surgeries decreased 3.7%. The high out-of-pocket plans
increased the practices bad debt obligations and further research was needed to monitor
the changes in reimbursements as insurance companies change their low-income markets
(Hempstead et al., 2015).
ICD-10 Implementation
The ICD-10 implementation delay from October 2014 to 2015 by the Centers for
Medicare & Medicaid Services cost the healthcare industry was beneficial for providers
who ignored the change. However, others had invested in the implementation, spent
considerable amounts in training, and upgraded systems and staff with costs to the
healthcare industry of approximately $1 billion to $6.6 billion, depending on the practice
or health system size (Daly, 2014). Healthcare providers pushed for the delay with the
support of an American Medical Association-sponsored report finding that
implementation will be more expensive than previously estimated with costs in the range
from $56,639 to $226,105 for small practices; $213,364 to $824,735 for medium-sized
practices; and about $2 million to more than $8 million for large practices. The previous
estimates were $83,290 for small practices, $285,195 for medium-sized practices and
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more than $2.7 million for large ones (Robeznieks, 2014). Many practices exhausted
their financial resources getting ready for the 2014 deadline that their budgets did not
allow for additional costs associated with the delay to 2015 (Carney, 2014).
ICD-10 was an extensive shift in the coding system that affected every aspect of
healthcare operation (Sanders et al., 2012). Practices prepared for a contingency plan in
case the implementation was not smooth and if there was a significant decrease in
revenue (Spear, 2015). The transition to ICD-10 was the largest mandate in U.S.
healthcare history to date and required governance, education, and documentation
(Goldstein, 2015).
After the ICD-10 Transition
The CPT changes as well as the new ICD-10 code-set was challenging for all
providers regardless if practice or hospital-based in 2015 (Carney, 2014). Experts
suggested practices have at least three months cash on hand if claims were slow to
process after the implementation; with everyone converting at once, there were delays in
processing (Carney, 2014). There were also changes in methodologies for payments for
some providers and facilities, this change required improved documentation by providers
(Carney, 2014). Medicare prolonged the specificity of ICD-10 (eg. C81 versus C81.00)
until October 1, 2016 before rejecting claims for payment; ensuring the correct diagnosis
and medical necessity were vital when billing (Dowling, 2015).
The Medical Group Management Association (MGMA) conducted a post-ICD-10
implementation survey and respondents listed the top 2016 priorities as optimizing
revenue cycle management, working toward a value-based care model and automating
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patient collections (Bradley, 2016). During the postimplementation period, healthcare
leaders identified and resolved issues as quickly as possible such as claim denials,
rejections, or coding backlogs to minimize declines in productivity and cash-flow
(Tennant, 2013).
Revenue Cycle Management
Healthcare leaders needed to focus more on revenue cycle management while
running a very efficient business to maintain profit levels while searching for new
opportunities to enhance the practice (Rutherford, 2017). The demands of running a
successful modern medical practice requires more staff and time than it did five years
ago, requiring providers to use a successful revenue cycle management process (Bentley
& Robinson, 2016). The healthcare revenue cycle includes more than just billing and
collecting fees; it dealt with every aspect of the patient process and requires
knowledgeable, efficient, organized, and dedicated administrative staff (Bentley &
Robinson, 2016). The Centers for Medicare and Medicaid Services rejects nearly 26% of
all claims and up to 40% of those claims were never resubmitted, which can account for a
10% of loss revenues for the practice (Bentley & Robinson, 2016). A successful revenue
cycle management system could increase payments and decrease bad debt write-offs
affecting the practice with revenue cycle optimization by utilizing technology,
knowledge, and commitment to increase reimbursement from payers and patients in the
shortest possible time (Bentley & Robinson, 2016).
For the implementation of ICD-10, providers needing to educate themselves
about electronic records, practice management systems, clinical documentation, ICD-10
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code-set conversion, cash flow and how to research new payment models (Carney, 2014).
Practice managers reviewed data from the first post transition months to help optimize
revenue by identifying denial and rejection trends (Bradley, 2016).
Definitions
The following terms were defined for the purpose of this study:
Allowed amount: The amount an insurance plan will pay for a covered health care
service (HealthCare.gov, n.d.).
Current procedural terminology (CPT): Current procedural terminology refers to
codes used to record what procedures were being completed in healthcare. First
published in 1966 and were developed, maintained, and copyrighted by the American
Medical Association (AMA). Thousands of CPT codes were in use, and they were
updated annually (AMA, 2018).
Commercial payer: Insurance companies that receive premiums from the patients
to provide coverage that was provided by private companies, such as United Healthcare,
Aetna, Cigna, and Blue Cross and Blue Shield (Archer & Marmor, 2012).
Government payer: Federally or State funded insurance plans for those with low
income or disabilities, such as Medicare and Medicaid (Archer & Marmor, 2012).
International Classification of Diseases (ICD): The International Classification of
Diseases was the standard diagnostic tool for epidemiology, health management, and
clinical purposes in the United States was established by the World Health Organization
(WHO) and updated annually (WHO, 2018).
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International Classification of Diseases, 9th Revision (ICD-9): The 9th revision
was adopted in United States in 1979. The code set was updated annually. ICD-9 was
approximately 17,000 3-4 numeric or alpha-numeric data set (AAPC, 2018a)
International Classification of Diseases, 10th Revision (ICD-10): International
Classification of Diseases, 10th Revision, Clinical Modification replaced ICD-9 codes on
Oct 1, 2015, with 141,000 alpha numeric code set up to 7 characters to include diagnostic
and in-patient procedural codes. (AAPC, 2018b)
Intraoperative neurophysiological monitoring: Attempts to minimize neurological
morbidity during surgical procedures by monitoring changes in brain, spinal cord, and
peripheral nerve functions (American Society of Neurophysiological Monitoring, 2018).
Medical coding: Medical coding was the conversion of diagnosis, procedures,
medical services, and equipment for into universal medical alphanumeric codes for
claims submission to insurance carriers (AAPC, 2018c).
Medical billing: Medical billing was submitted with follow-up on claims with
insurance companies to receive payment for services rendered (AAPC, 2018d).
Reimbursement: Providers were paid on a “fee-for-service” basis, the insurance
carriers pays the provider a certain amount based on the service provided and the allowed
amount (Humana, 2018).
Revenue cycle: The entire cycle of a patient encounter from scheduling to final
payment (Singh, Mindel, & Mathiassen, 2017).
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Assumptions
The believed assumptions of this study, but cannot be demonstrated to be true,
that were critical to the meaningfulness of this study were that the data collected by the
two intraoperative neurophysiological monitoring companies was reported precisely and
correctly. The data provided from the Medicare fee schedule were not a concern, but if
the data from intraoperative neurophysiological monitoring companies for the
commercial data were incorrect, the commercial analysis of the reimbursements would be
affected. There was no assumption that the codes were bundled affecting the
reimbursements. The change in the Medicare Fee Schedule will be calculated at the
inflation rate of 1.4% from the year 2014 to 2016 to address assumptions in inflation or
deflation of pricing. (U.S. Inflation Calculator, 2018).
Scope and Delimitations
The scope of the study was to understand the difference between reimbursements
for intraoperative neurophysiological monitoring after the implementation of ICD-10 in
Oklahoma and does not include outside of the state. The specific focus was chosen
because these changes were key components for healthcare leadership to effectively run a
practice. Research was completed on the implementation costs and effects on medical
practices, but not the aftermath, in specific medical specialties.
The delimitations of the study is the inability to compare the data of commercial
reimbursements for other intraoperative neurophysiological monitoring companies in
Oklahoma, as this was proprietary information. Potential generalizability will be avoided
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as most intraoperative neurophysiological monitoring companies will need this study for
their survival.
Significance, Summary, and Conclusions
The preliminary evidence to justify the study was the lack of previous studies on
neuromonitoring for ICD-10 conversion, reimbursements, administration, or even
revenue cycle management; although, there were several studies that focused on the
clinical aspect. Research of literature produced a paucity of studies, which provide a
supporting argument for research in this area. This study may contribute to the
intraoperative neurophysiological monitoring leadership practices by providing changes
in reimbursement to allow management to successfully operate the business. The
practical applications for this study will aid in the viability of the small intraoperative
neurophysiological monitoring companies through sustainability of business and possible
growth which will lead to positive social change.
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Section 2: Research Design and Data Collection
Introduction
The study may provide an understanding specific for health care leaders regarding
the changes in reimbursement from following the ICD-10 implementation in
intraoperative neurophysiological monitoring companies in Oklahoma. The methods and
procedures described in this section describe the research including sampling size,
analysis plan, and threats to validity.
Research Design and Rationale
The study variables were intraoperative neurophysiological monitoring CPT
codes (Figure 1), the reimbursements from Medicare, and other commercial insurance
companies for those codes. The quantitative research design was correlational in order to
study the relationship between the different reimbursement rates on intraoperative
neurophysiological monitoring CPT codes before and after the implementation of ICD10. The study can be completed with minimal time and resource constraints to interpret
the relationship between the reimbursements and CPT codes. Correlational research
determines the relationship, if any, between two or more variables using statistical data to
interpret (Creswell, 2009). In this study I found a relationship between the changes in
reimbursements related to the implementation of ICD-10 for intraoperative
neurophysiological monitoring for the state of Oklahoma.
Methodology
The methodology for the study included the population, sampling, secondary data
sets, and variances in reimbursement for the CPT codes used in intraoperative
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neurophysiological monitoring from 2014 to 2016. The period of the conversion was
from ICD-9 to ICD-10. Accounting for the possible yearly inflation allowed in the codes,
a review of the allowable codes from each year used for comparison regarding what was
paid and compared to the percentage of Medicare rates.
Population
The population for this study includes more than 10,000 CPT codes created and
maintained by the AMA (2018) and the Centers for Medicare and Medicaid Services Fee
Schedule.
Sampling
The sampling of the population includes 15 intraoperative neurophysiological
monitoring codes of CPT with and without modifiers with the specific fee schedule for
the state of Oklahoma from the Centers for Medicare and Medicaid Services Fee
Schedule for the years 2014 and 2016. Medicare rates were adjusted based on the
practice costs to provide the service per area (CMS, 2018). For example, the cost for
intraoperative neurophysiological monitoring in New York would be higher than
Oklahoma due to the cost of living for salaries and insurance. The codes listed in Table 1
were the inclusion and the codes that were not related to intraoperative
neurophysiological monitoring were the exclusion. The fee schedules for states other than
Oklahoma were also an exclusion.
The procedures for recruitment, participation, and data collection associated with
the secondary data set of the Medicare fee schedule was published on their website. The
possible commercial insurance reimbursement rates data will be provided by two

20
Oklahoma intraoperative neurophysiological monitoring companies. Permission to gain
access to the data of intraoperative neurophysiological monitoring companies’
proprietary commercial reimbursements was requested verbally and approved.
Instruction and Operationalization of Constructs
The published data sets were the Centers for Medicare and Medicaid Services fee
schedule for the years 2014 and 2016. These were appropriate for the current study to
determine if there were any changes in reimbursements due to the change from ICD-9 to
ICD-10. The data was available to the public not requiring specific permissions for use.
The Centers for Medicare and Medicaid Services fee schedule was a governmental
published dataset that was reliable, valid, and relevant to every healthcare provide in the
United States.
Operationalization
The variables of intraoperative neurophysiological monitoring CPTs (Figure 1)
included the description of the code. Each variable was measured on the geographic
practice cost index and the relative value units for work, practice expense, and
malpractice to determine the rate in the Centers for Medicare and Medicaid Services fee
schedule (CMS, 2018). An example was that code 95813 was valued at $25.14 for 2014
in the Centers for Medicare and Medicaid Services fee schedule.
Data Analysis Plan
The data analysis plan explained how the data for the study was cleaned,
transformed, and analyzed. The cleaning of data removed any univariate outliers,
missing data, and assess for normality. The variables of the fee schedule were assessed
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for univariate outliers with a standard deviation of greater than ±3.29 from the variable’s
mean. Missing data was addressed by eliminating the observation where possible.
The software used for the analyses was SPSS® and Microsoft Excel. The data
sets were downloaded from the public websites for Medicare, Medicaid, and Workman’s
Compensation. The specific data was extracting the specific intraoperative
neurophysiological monitoring CPT codes from the different fee schedule datasets to
import into SPSS® for 2014 and 2016. Manual review and extraction of reimbursements
for commercial carriers were entered in SPSS® for analysis after data cleaning and
screening. The data cleaning and scrubbing will ensure there was no patient identifiers
available in the data. The CPT code reimbursements from 2014 will be compared to
those from 2016 to determine the statistical difference, if any for Medicare and the
commercial carriers. This study could be replicated with the Medicare Fee Schedule for
other states or specialties except for the proprietary commercial reimbursements.
Research Questions
The restated research questions and hypotheses as written in Section 1.
Research Question1: To what extent was the difference, if any, between the
independent variables of intraoperative neurophysiological monitoring CPT codes and
dependent continuous variables within the Medicare Fee Schedule for 2014 and 2016 for
intraoperative neurophysiological monitoring companies in Oklahoma?
H01: There was not a statistically significant difference on independent variables
of intraoperative neurophysiological monitoring CPT codes and dependent continuous
variables of the Medicare Fee Schedule for 2014 and 2016.
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Ha1: There was a statistically significant difference on independent variables of
intraoperative neurophysiological monitoring CPT codes and dependent continuous
variables of the Medicare Fee Schedule for 2014 and 2016.
Research Question 2: What was the difference between the independent variables
of intraoperative neurophysiological monitoring CPT codes and the dependent
continuous variables of the rate paid by commercial carriers for 2014 and 2016 for
intraoperative neurophysiological monitoring companies in Oklahoma?
H02: There was not a statistically significant difference between the independent
variables of intraoperative neurophysiological monitoring CPT codes and dependent
continuous variables of the rate paid by commercial carriers for 2014 and 2016.
Ha2: There was a statistically significant difference between the independent
variables of intraoperative neurophysiological monitoring CPT codes and dependent
continuous variables of the rate paid by commercial carriers for 2014 and 2016.
Research Question 3: How did the conversion from ICD-9 to ICD-10 (i.e., 2014
versus 2016) affect the revenue cycle management for intraoperative neurophysiological
monitoring companies in Oklahoma?
H03: The conversion from ICD-9 to ICD-10 (i.e., 2014 versus 2016) positively
affected the revenue cycle management for intraoperative neurophysiological monitoring
companies in Oklahoma.
Ha3: The conversion from ICD-9 to ICD-10 (i.e., 2014 versus 2016) negatively
affected the revenue cycle management for intraoperative neurophysiological monitoring
companies in Oklahoma.
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Statistical Tests
Sample t tests were used to test the hypotheses above as the variables were
related. The CPT code was related to the respected fee schedule amount for that code.
The variables continuous and will be comparing the means on each CPT code for the
reimbursements from 2014 and 2016. Multiple tables will clarify the multiple statistical
sample t tests for the difference between Medicare and commercial reimbursements for
the two years. The study should not have any covariate or cofounding variables due to its
nature. The final stage of the analysis plan was the interpretation of the research. A
summary of the quantitative data was provided with the statistical information visually
displayed to increase understanding.
Threats to Validity
Due to the nature of the study and use of secondary statistical data, a known threat
to external, internal, or construct validity would be scrubbing or cleaning of the data. The
data were carefully scrubbed and cleaned to ensure no patient identifiers will be
available.
Ethical Procedures
The datasets were from open-sourced peer-reviewed and government sources
causing no ethical concerns. The datasets were specifically financial with no human
participant involvement. Ethical procedures were taking into consideration to protect
confidential data to ensure the data was secure with minimal access. There were no
ethical concerns related to recruitment materials and processes as described in secondary
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data set materials. The use of commercial insurance carrier reimbursement data from
intraoperative neurophysiological monitoring companies in Oklahoma was proprietary
and therefore anonymous. The only ethical concern could possibly be using secondary
data within the author’s own work environment for the commercial insurance
reimbursement research question.
Summary
The methods and procedures described in this section describe the research
including sampling size, analysis plan, and threats to validity for the study on the changes
in reimbursement from following the ICD-10 implementation in intraoperative
neurophysiological monitoring companies in Oklahoma. The results and findings of this
study will be ne interpreted in the results and findings section.
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Section 3: Presentation of the Results and Findings
Introduction
The purpose of this correlational, quantitative study was to provide understanding
for health care leaders regarding the changes in reimbursement following the ICD-10
implementation in intraoperative neurophysiological monitoring companies in Oklahoma.
The overarching research question was as follows: What was the statistical significance,
if any, between the changes in reimbursements from following the ICD-10
implementation in intraoperative neurophysiological monitoring companies in
Oklahoma? The hypothesis for the research question was that there was a statistical
significance in the change of reimbursements. In the following section, I will describe
the data collection of secondary data sets and the results.
Data Collection of Secondary Data Sets
The time frame for data collection was 3 business days as Medicare, Medicaid,
and Workman’s Compensation data was available from their public websites. The data
response rates from all carriers was 100% indication for a confidence interval for the
study.
There were no discrepancies in the use of the secondary data set from the plan
presented in Section 2. The baseline descriptive and demographic characteristics of the
sample include CPT codes and the appropriate allowed amount per the insurance carrier
or the reimbursement amount from their fee schedule. The sample of the intraoperative
neurophysiologic monitoring CPT codes and reimbursements was a representative
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sample of the population of the over 8,000 total CPT codes. The sample includes all the
intraoperative neurophysiologic monitoring CPT codes.
Results
The descriptive statistics from the data on the changes in reimbursements for
intraoperative neurophysiological monitoring are represented in Table 2 per CPT code.
Due to the type of data studied, standard deviations were high and not consistent. Data
on the reimbursements for intraoperative neurophysiological monitoring CPT codes from
the Oklahoma Workman’s Compensation, and some of the commercial carriers had no
change in reimbursements from 2014 to 2016. The lack of change affected the mean,
median, and mode, adding to the variety of standard deviations in the data.
Table 2
Descriptive Statistics
Code
G0453

Description
Remote Intraoperative Monitoring

Mean
$1.95

Median
$0.15

Mode
$0

95925
95926
95938
95927
95928
95939
95937
95861
95870
51785
95812
95813

Upper SSEP Bilateral
Lower SSEP Bilateral
Upper & Lower SSEP Bilateral
Trunk/Head SSEP Bilateral
TcMEP Upper Limbs
TcMEP Upper & Lower Limbs
NeuroMusclular Junction
EMG Two Extremity
Trunk/Extremity EMG
Anal Sphincter
EEG 41-60 minutes
EEG greater than 1 hour

$-18.38
$-18.88
$-1.59
$-12.03
$-20.58
$-20.05
$-0.51
$-2.89
$-1.55
$-4.74
$-29.96
$-26.27

$-7.83
$-3.20
$0
$-8.86
$-12.31
$-8.71
$0
$0
$0
$0
$-22.12
$-13.94

$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
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The statistical assumptions appropriate to the study are the scale of measurement,
simple random sample of the total population, normal distribution, and homogeneity of
variance. The statistical analysis findings organized by CPT code and carrier indicated
that there was an overall decrease in reimbursements among all carriers from 2014 to
2016, especially when adjusted for the 1.4% inflation rate. The carriers that did not have
a change in reimbursements from 2014 to 2016 indicated a 1.4% decrease because of the
inflation rate.
Some CPT codes showed an increase but not enough to outweigh the decrease as
a whole. When combing all data as a whole, there was an average of 10% decrease in
reimbursements of the carriers that had a change in reimbursements. Overall with the
carriers with no change in reimbursements but adjusted with the 1.4% inflation rate, the
overall change on reimbursements was -6%.
The highest percentage of change per procedure code and insurance carrier was
11% for remote monitoring (G0453) for a commercial carrier and the lowest was -46%
for lower somatosensory evoked potentials (95926) for Medicaid. Medicaid had the
largest change in reimbursements of -18% and the smallest change of Medicare at -6%.
The changes in reimbursements from 2014 to 2016 are indicated in Table 3.
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Table 3
Percentage of Change from 2014 to 2016
Code
G0453
95925
95926
95938
95927
95928
95939
95937
95861
95870
51785
95812
95813
Averages

Description
Remote Intraoperative Monitoring
Upper SSEP Bilateral
Lower SSEP Bilateral
Upper & Lower SSEP Bilateral
Trunk/Head SSEP Bilateral
TcMEP Upper Limbs
TcMEP Upper & Lower Limbs
NeuroMusclular Junction
EMG Two Extremity
Trunk/Extremity EMG
Anal Sphincter
EEG 41-60 minutes
EEG greater than 1 hour

Medicaid
11%
-38%
-45%
-8%
-25%
-26%
-12%
-6%
-12%
-14%
-13%
-20%
-15%
-18%

Medicare
1%
-11%
-5%
2%
-14%
-12%
2%
-4%
2%
6%
3%
-23%
-19%
-6%

Overall Average Change per Carrier
0%
-2%
-4%
-6%
-8%
-10%
-12%
-14%
-16%
-18%
-20%

-6%

-7%

-18%
Mediciad

Medicare

Figure 1. Overall average change per carrier.

Commerical

Commercial
19%
-26%
-32%
4%
-14%
-15%
-2%
4%
-2%
-4%
-3%
-9%
-5%
-7%
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Percentage of Reimbursement Change per CPT
Code
10%
0%
-10%

G0453 95939 95938 95937 95929 95928 95927 95926 95925 95870 95861 95813
6%
4%
3%
2%
2%2%

-8%

-4%
-6%

-20%
-30%

-4%

-5%

-8%

-11%

-14%
-12%
-15% -15% -14%

-25%
-27% -26%

-14%

-2%

-12%

-26%

-5%

-3%
-9%
-13%

-15%
-19% -20%
-23%

-32%

-40%

-38%
-45%

-50%
Mediciad

Medicare

Commerical

Figure 2. Percentage of reimbursements change per CPT code.

The intraoperative neurophysiological monitoring procedure with the greatest
mean annual decreases in reimbursement was the lower Somatosensory Evoked
Potentials (SSEP) with -28% amongst all carriers. The intraoperative neurophysiological
monitoring procedures with the least annual reimbursement decreases were transcranial
electrical motor potential (TcMEP) monitoring and Electromyography (EMG) with -2%
amongst all carriers.
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Table 4
Percentage of Change from 2014 to 2016 Mean
Code
G0453
95925
95926
95938
95927
95928
95939
95937
95861
95870
51785
95812
95813

Description
Remote Intraoperative Monitoring
Upper SSEP Bilateral
Lower SSEP Bilateral
Upper & Lower SSEP Bilateral
Trunk/Head SSEP Bilateral
TcMEP Upper Limbs
TcMEP Upper & Lower Limbs
NeuroMusclular Junction
EMG Two Extremity
Trunk/Extremity EMG
Anal Sphincter
EEG 41-60 minutes
EEG greater than 1 hour

Mean
11%
-25%
-28%
-2%
-18%
-18%
-4%
-2%
-4%
-4%
-4%
-17%
-13%

Average Change per CPT Code
15%
10%

G0453 95925 95926 95938 95927 95928 95939 95937 95861 95870 51785 95812 95813
11%

5%
0%

-2%

-5%

-4%

-2%
-4%

-4%

-4%

-10%

-13%

-15%

-18% -18%

-20%
-25%
-30%

-25%

-28%

Figure 4. Average change per CPT code.

-17%
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The research questions and hypotheses as written in Section 1 were as follows:
RQ 1: To what extent was the difference, if any, between the independent
variables of intraoperative neurophysiological monitoring CPT codes and dependent
continuous variables within the Medicare Fee Schedule for 2014 and 2016 for
intraoperative neurophysiological monitoring companies in Oklahoma?
H01: There was not a statistically significant difference on independent variables
of intraoperative neurophysiological monitoring CPT codes and dependent
continuous variables of the Medicare Fee Schedule for 2014 and 2016.
Ha1: There was a statistically significant difference on independent variables of
intraoperative neurophysiological monitoring CPT codes and dependent
continuous variables of the Medicare Fee Schedule for 2014 and 2016.
Ha1 was the supported hypothesis with a 6 % decrease in Medicare
reimbursements for intraoperative neurophysiological monitoring CPT codes for 2014
and 2016.
RQ 2: What was the difference between the independent variables of
intraoperative neurophysiological monitoring CPT codes and the dependent continuous
variables of the rate paid by commercial carriers for 2014 and 2016 for intraoperative
neurophysiological monitoring companies in Oklahoma?
H02: There was not a statistically significant difference between the independent
variables of intraoperative neurophysiological monitoring CPT codes and
dependent continuous variables of the rate paid by commercial carriers for 2014
and 2016.
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Ha2: There was a statistically significant difference between the independent
variables of intraoperative neurophysiological monitoring CPT codes and
dependent continuous variables of the rate paid by commercial carriers for 2014
and 2016.
Ha2 was the supported hypothesis with an overall decrease of 3% of
intraoperative neurophysiological monitoring CPT codes for 2014 and 2016.
RQ 3: How did the conversion from ICD-9 to ICD-10 (i.e., 2014 versus 2016)
affect the revenue cycle management for intraoperative neurophysiological monitoring
companies in Oklahoma?
H03: The conversion from ICD-9 to ICD-10 (i.e., 2014 versus 2016) positively
affected the revenue cycle management for intraoperative neurophysiological
monitoring companies in Oklahoma.
Ha3: The conversion from ICD-9 to ICD-10 (i.e., 2014 versus 2016) negatively
affected the revenue cycle management for intraoperative neurophysiological
monitoring companies in Oklahoma.
Ha3 was the supported hypothesis with an overall decrease in reimbursements of
6% when including the carriers with no change and a 10% decrease with the carriers that
had changes in reimbursements.
Summary
The methods and procedures described in this section represented the results of
the study on changes in reimbursements for intraoperative neurophysiological monitoring
CPT codes for 2014 and 2016. Ha1 was the supported hypothesis for RQ 1, with a 6%
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decrease in Medicare reimbursements for intraoperative neurophysiological monitoring
CPT codes for 2014 and 2016. Ha2 was the supported hypothesis for RQ 2, with an
overall decrease of 3% of intraoperative neurophysiological monitoring CPT codes for
2014 and 2016. Ha3 was the supported hypothesis for RQ 3, with an overall decrease in
reimbursements of 6% when including the carriers with no change and a 10% decrease
with the carriers that had changes in reimbursements. The findings of the study indicated
an overall decrease in reimbursements after implementation of ICD-10 for intraoperative
neurophysiological monitoring. In Section 4, I will present the application for
professional practice and social change.
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Section 4: Application to Professional Practice and Implications for Social Change
Introduction
The purpose and nature of this correlational, quantitative study was to provide
health care leaders with an understanding of the changes in reimbursement following
ICD-10 implementation in intraoperative neurophysiological monitoring companies in
Oklahoma. The findings of the study indicated an overall 6-10% decrease in
reimbursements for intraoperative neurophysiological monitoring after implementation of
ICD-10.
Interpretation of the Findings
The decrease in reimbursements does not offset the high costs of ICD-10
implementation. Healthcare leaders will need to find additional revenue-generating
options while keeping costs down. Medicare had an overall decrease of reimbursements
of 6%, whereas Medicaid had a much larger decrease of 18%. The results of this study
are comparable to the study by Eltorai et al. (2018) on orthopedic procedures with a
decrease in reimbursements. The continued increase in costs and decrease in
reimbursements are compounding the challenges for healthcare leaders for cost-effective
business. Other revenue-generating options will need to be considered to sustain
business.
Limitations of the Study
There were limitations due to the physician-contracted rates with the payers, as
some providers could have contracted higher rates than those studied. Limitations might
include payer mix variations per carrier. Participation was limited by geographic location
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of Oklahoma and did not include outside of the state. There could be limitations
pertaining to no control over the providers who participated in the study.
Recommendations
Recommendations for further research, grounded in the strengths and limitations
of the current study as well as the literature reviewed, would be to research the changes in
intraoperative neurophysiological monitoring for other states and other specialties.
Professional Practice
Recommendations for professional practice include continued monitoring of
reimbursement changes to ensure the decrease levels out in following years. If the
decrease does not level out, renegotiating the commercial carrier contracts will be
required by healthcare leaders to offset the carriers that have a set fee schedule that is not
negotiable, such as Medicare and Medicaid. Contract management will be key to
maintain reimbursements with the rising costs of business. Changes in reimbursements
affect the cash flow of the practice and other operating capital.
Positive Social Change
The ICD-10 implementation delay from October 2014 to 2015 by the CMS was
welcomed by providers that were ignoring the change, not by others that had already
invested in the implementation, spending considerable amounts in training, upgrading
systems, and staff with overall costs to the healthcare industry of approximately $1
billion to $6.6 billion (Daly, 2014). ICD-10 was an extensive shift in the coding system
that will affect every aspect of healthcare operation (Sanders et al., 2012). Healthcare
leaders need to focus more on revenue cycle management while running a very efficient
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business to maintain profit levels while searching for new opportunities to enhance the
practice (Rutherford, 2017). These changes affect their livelihood of several small
intraoperative neurophysiological monitoring companies in Oklahoma. This study on the
changes in reimbursement from ICD-9 to ICD-10 assisted healthcare leadership to make
the necessary changes in business and their revenue cycle management to ensure the
stability and future of the Oklahoma intraoperative neurophysiological monitoring
companies.
Conclusion
This study evaluated the changes in reimbursements due to the change from ICD9 to ICD-10 for intraoperative neurophysiological monitoring in Oklahoma. The
transition from ICD-9 to ICD-10 was a massive undertaking by physicians, hospitals, and
clinics with high costs and without a clear understanding of the future impact. Healthcare
leaders can effectively manage their practice and revenue cycle management with the
information provided from this study to stay profitable and compete within the market.
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